Caribou Biosciences, Inc.
corporate_fare Company Profile
Caribou Biosciences, Inc. (NASDAQ:CRBU) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for CRBU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for CRBU spans 10-Q, 8-K, PRE 14A, 10-K.
Recent high-impact activity:
- Caribou 10-Q: $94.8M Cash, $26.6M Q3 Loss, Nasdaq Bid-Price Deficiency Disclosed
- Caribou Posts Q3 Loss of $26.6M, Cash Falls to $94.8M Amid Strategic Review
- Caribou Halts Lead CAR-T Programs, CFO to Exit as Strategic Review Begins
- Caribou Halts Lead CAR-T Programs, Explores Strategic Alternatives
- Caribou Halts CAR-T Programs, Cuts Workforce, and Explores Sale
Financial Snapshot
Short Interest & Short Volume
6.04 days to coverFINRA reported short interest of 14,892,848 shares in CRBU as of the October 30, 2026 settlement, a 18.6% increase from the prior period — about 6.0 days to cover at its recent average daily volume. On November 20, 2026, 45.7% of CRBU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.